Randomized phase 2 neoadjuvant trial evaluating anastrozole and fulvestrant efficacy for postmenopausal, estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients: Results of the UNICANCER CARMINA 02 French trial (UCBG 0609).

Published in:

2016

By:

• Lerebours, Florence;
• Rivera, Sofia;
• Mouret‐Reynier, Marie‐Ange;
• Alran, Severine;
• Venat‐Bouvet, Laurence;
• Kerbrat, Pierre;
• Salmon, Remy;
• Becette, Veronique;
• Bourgier, Céline;
• Cherel, Pascal;
• Boussion, Véronique;
• Balleyguier, Corinne;
• Thibault, Fabienne;
• Lavau‐Denes, Sandrine;
• Nabholz, Jean‐Marc;
• Sigal, Brigitte;
• Trassard, Martine;
• Mathieu, Marie‐Christine;
• Martin, Anne‐Laure;
• Lemonnier, Jerome

Publication type:

journal article